These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18224646)

  • 1. Stepwise combinatorial evolution of Akt bisubstrate inhibitors.
    Lee JH; Kumar S; Lawrence DS
    Chembiochem; 2008 Mar; 9(4):507-9. PubMed ID: 18224646
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and SAR of indazole-pyridine based protein kinase B/Akt inhibitors.
    Woods KW; Fischer JP; Claiborne A; Li T; Thomas SA; Zhu GD; Diebold RB; Liu X; Shi Y; Klinghofer V; Han EK; Guan R; Magnone SR; Johnson EF; Bouska JJ; Olson AM; de Jong R; Oltersdorf T; Luo Y; Rosenberg SH; Giranda VL; Li Q
    Bioorg Med Chem; 2006 Oct; 14(20):6832-46. PubMed ID: 16843670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and SAR of spirochromane Akt inhibitors.
    Kallan NC; Spencer KL; Blake JF; Xu R; Heizer J; Bencsik JR; Mitchell IS; Gloor SL; Martinson M; Risom T; Gross SD; Morales TH; Wu WI; Vigers GP; Brandhuber BJ; Skelton NJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2410-4. PubMed ID: 21392984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-conjugated peptide inhibitors for calmodulin-dependent protein kinase II.
    Ahn DR; Han KC; Kwon HS; Yang EG
    Bioorg Med Chem Lett; 2007 Jan; 17(1):147-51. PubMed ID: 17035012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of pyridine-pyrazolopyridine-based inhibitors of protein kinase B/Akt.
    Zhu GD; Gong J; Gandhi VB; Woods K; Luo Y; Liu X; Guan R; Klinghofer V; Johnson EF; Stoll VS; Mamo M; Li Q; Rosenberg SH; Giranda VL
    Bioorg Med Chem; 2007 Mar; 15(6):2441-52. PubMed ID: 17258463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminofurazans as potent inhibitors of AKT kinase.
    Rouse MB; Seefeld MA; Leber JD; McNulty KC; Sun L; Miller WH; Zhang S; Minthorn EA; Concha NO; Choudhry AE; Schaber MD; Heerding DA
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1508-11. PubMed ID: 19179070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase.
    Heerding DA; Rhodes N; Leber JD; Clark TJ; Keenan RM; Lafrance LV; Li M; Safonov IG; Takata DT; Venslavsky JW; Yamashita DS; Choudhry AE; Copeland RA; Lai Z; Schaber MD; Tummino PJ; Strum SL; Wood ER; Duckett DR; Eberwein D; Knick VB; Lansing TJ; McConnell RT; Zhang S; Minthorn EA; Concha NO; Warren GL; Kumar R
    J Med Chem; 2008 Sep; 51(18):5663-79. PubMed ID: 18800763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship studies of peptidomimetic PKB/Akt inhibitors: the significance of backbone interactions.
    Tal-Gan Y; Freeman NS; Klein S; Levitzki A; Gilon C
    Bioorg Med Chem; 2010 Apr; 18(8):2976-85. PubMed ID: 20347317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel protein kinase B inhibitor by structure-based virtual screening.
    Medina-Franco JL; Giulianotti MA; Yu Y; Shen L; Yao L; Singh N
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4634-8. PubMed ID: 19604696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Straightforward synthesis of novel Akt inhibitors based on a glucose scaffold.
    Cipolla L; Redaelli C; Granucci F; Zampella G; Zaza A; Chisci R; Nicotra F
    Carbohydr Res; 2010 Jul; 345(10):1291-8. PubMed ID: 20044079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.
    Xu R; Banka A; Blake JF; Mitchell IS; Wallace EM; Bencsik JR; Kallan NC; Spencer KL; Gloor SL; Martinson M; Risom T; Gross SD; Morales TH; Wu WI; Vigers GP; Brandhuber BJ; Skelton NJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2335-40. PubMed ID: 21420856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of pyridopyrimidines as potent Akt1/2 inhibitors.
    Wu Z; Hartnett JC; Neilson LA; Robinson RG; Fu S; Barnett SF; Defeo-Jones D; Jones RE; Kral AM; Huber HE; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1274-9. PubMed ID: 18249537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid assembly of diverse and potent allosteric Akt inhibitors.
    Wu Z; Robinson RG; Fu S; Barnett SF; Defeo-Jones D; Jones RE; Kral AM; Huber HE; Kohl NE; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2211-4. PubMed ID: 18296048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitors.
    van Wandelen LT; van Ameijde J; Mady AS; Wammes AE; Bode A; Poot AJ; Ruijtenbeek R; Liskamp RM
    ChemMedChem; 2012 Dec; 7(12):2113-21. PubMed ID: 23139239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of 2,3,5-trisubstituted pyridine derivatives as potent allosteric Akt1 and Akt2 inhibitors.
    Hartnett JC; Barnett SF; Bilodeau MT; Defeo-Jones D; Hartman GD; Huber HE; Jones RE; Kral AM; Robinson RG; Wu Z
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2194-7. PubMed ID: 18294842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbocyclic 3'-deoxyadenosine-based highly potent bisubstrate-analog inhibitor of basophilic protein kinases.
    Enkvist E; Raidaru G; Vaasa A; Pehk T; Lavogina D; Uri A
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5336-9. PubMed ID: 17716894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and efficient access to phenylamino-pyrimidine type protein kinase C inhibitors utilizing a Negishi cross-coupling strategy.
    Stanetty P; Hattinger G; Schnürch M; Mihovilovic MD
    J Org Chem; 2005 Jun; 70(13):5215-20. PubMed ID: 15960526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of deconstruction analogues of 7-deoxykalafungin as AKT kinase inhibitors.
    Korwar S; Nguyen T; Ellis KC
    Bioorg Med Chem Lett; 2014 Jan; 24(1):271-4. PubMed ID: 24321345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine.
    Hu C; Solomon VR; Ulibarri G; Lee H
    Bioorg Med Chem; 2008 Sep; 16(17):7888-93. PubMed ID: 18691894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors.
    Seefeld MA; Rouse MB; McNulty KC; Sun L; Wang J; Yamashita DS; Luengo JI; Zhang S; Minthorn EA; Concha NO; Heerding DA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2244-8. PubMed ID: 19285393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.